Follow
Emily Boja
Title
Cited by
Cited by
Year
Proteogenomic characterization of human colon and rectal cancer.
LDC Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ ...
Nature 513, 382-387, 2014
14022014
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
8872016
How many human proteoforms are there?
R Aebersold, JN Agar, IJ Amster, MS Baker, CR Bertozzi, ES Boja, ...
Nature chemical biology 14 (3), 206-214, 2018
7682018
Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma
Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song, C Huang, J Li, X Dong, ...
Cell 179 (2), 561-577. e22, 2019
7302019
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
5602019
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5552014
Integrated proteogenomic characterization of clear cell renal cell carcinoma
DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ...
Cell 179 (4), 964-983. e31, 2019
4832019
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4482020
Reversible glutathionylation regulates actin polymerization in A431 cells
J Wang, ES Boja, W Tan, E Tekle, HM Fales, S English, JJ Mieyal, ...
Journal of Biological Chemistry 276 (51), 47763-47766, 2001
4052001
Proteogenomic and metabolomic characterization of human glioblastoma
LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ...
Cancer cell 39 (4), 509-528. e20, 2021
3852021
Proteogenomic characterization of endometrial carcinoma
Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ...
Cell 180 (4), 729-748. e26, 2020
3212020
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ...
Cell 183 (5), 1436-1456. e31, 2020
3062020
Proteogenomic characterization of pancreatic ductal adenocarcinoma
L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ...
Cell 184 (19), 5031-5052. e26, 2021
2672021
Overalkylation of a protein digest with iodoacetamide
ES Boja, HM Fales
Analytical chemistry 73 (15), 3576-3582, 2001
2312001
Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry–based assays
AN Hoofnagle, JR Whiteaker, SA Carr, E Kuhn, T Liu, SA Massoni, ...
Clinical chemistry 62 (1), 48-69, 2016
2142016
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ...
Cancer cell 39 (3), 361-379. e16, 2021
2132021
Integrated proteogenomic characterization across major histological types of pediatric brain cancer
F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ...
Cell 183 (7), 1962-1985. e31, 2020
2002020
Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor–dependent signaling pathways in renal collecting duct cells
MM Rinschen, MJ Yu, G Wang, ES Boja, JD Hoffert, T Pisitkun, ...
Proceedings of the National Academy of Sciences 107 (8), 3882-3887, 2010
1922010
Structural characterization of native mouse zona pellucida proteins using mass spectrometry
ES Boja, T Hoodbhoy, HM Fales, J Dean
Journal of Biological Chemistry 278 (36), 34189-34202, 2003
1912003
Mass spectrometry‐based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins
ES Boja, H Rodriguez
Proteomics 12 (8), 1093-1110, 2012
1892012
The system can't perform the operation now. Try again later.
Articles 1–20